This article has been corrected: In Figure 4A, the image of the immunoblot for row ‘elF1’ in the CC column is an accidental duplicate of the ‘elF3B’ image in the ‘RC’ column of Figure 3A. The corrected Figure 4, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Figure 4. eIF1, eIF5 and eIF6 expression levels in low and high grade CC and RC.
(A) Western blot of eIF1, eIF5 and eIF6 from LG and HG CC and RC NNT. Equal amounts of protein from each pair were resolved on SDS PAGE and immunoblotted with antibodies directed against eIF1, eIF5, eIF6 and β-actin (loading control). (B) qRT-PCR of eIF1, eIF5 and eIF6 from LG and HG CC and RC compared to NNT. Three independent experiments were carried out. Bars represent mean ± SEM. *** p < 0.01, *** p < 0.001. Statistical analysis: 2-way ANOVA with Bonferroni posttest.
Original article: Oncotarget. 2017; 8:101224–101243. 101224-101243. https://doi.org/10.18632/oncotarget.20642